Hospira, Inc. (HSP) Q2 2010 Earnings Call Transcript July 28, 2010 9:00 am ET Executives Karen King – IR Chris Begley – Chairman and CEO Tom Werner – SVP, Finance and CFO Analysts Gregg Gilbert – Bank of America David Roman – Goldman Sachs Chris Schott – J.P. Morgan Gregory Hertz – Citi David Buck – Buckingham Research Ronny Gal – Sanford C. Bernstein Rick Wise – Leerink Swann Marshall Urist – Morgan Stanley Jayson Bedford – Raymond James Junaid Husain – Soleil Securities PresentationOperator
Welcome to Hospira's 2010 second quarter conference call. All lines have been placed on a listen-only-mode to prevent any background noise. Following the speakers’ remarks, there will be a question-and-answer period. I will now turn the call over to Karen King, Vice President of Investor Relations. Karen, you may begin your conference. Karen King Thank you. Good morning, everyone, and welcome to our conference call and webcast regarding Hospira’s financial results for the second quarter of 2010. Participating in today's call are Chris Begley, Chairman and Chief Executive Officer of Hospira, and Tom Werner, Senior Vice President, Finance and Chief Financial officer. We will be making some forward-looking statements today, which are subject to risks, uncertainties and other factors that may cause actual results to differ materially from those indicated. A discussion of these factors is included in the Risk Factors and MD&A sections in Hospira's latest annual report on Form 10-K and subsequent Form 10-Qs on file with the SEC. We undertake no obligation to release publicly any revisions to forward-looking statements as a result of subsequent events or developments.